Skip to main content
. 2015 May 11;10(5):e0125826. doi: 10.1371/journal.pone.0125826

Table 9. Frequency distribution of patients on second line treatment among those with confirmed immunological failure (n = 93).

On second line HAART Frequency, n Per cent, %
No 86 92.47
Yes 7 7.53
Total 93 100.00